Nanomedicine is big business, getting bigger.

Report: Nanomedicine Market to Surpass $160 Billion by 2015

Nanomedicine represents a principal domain of nanotechnology that offers capability to significantly change the course of treatment for life-threatening diseases. According to Global Industry Analysts Inc., a San Jose, Calif.-based publisher of market research studies, nanomedicine, unlike other therapies, enhances efficacy and significantly minimizes adversities associated with standard therapeutics. And, as GIA makes clear in its new, 698-page study, "Nanomedicine: A Global Strategic Business Report," the technology is big business, expected to exceed $160 billion in the next six years.

The report notes that the application of nanotechnology in the form of nanomedicine in areas including nano drug delivery, nanoanalytical contrast reagents, nanobiomaterials, and nanopharmaceuticals has been surging at a stable rate. Recent years have seen implementation of several programs by the industry to bridge the gap between outcomes of clinical research and commercial products. As a result, the present nanobiomaterial product pipeline poses a healthy picture with numerous novel products for use in health care applications, primarily in the form of coatings. Looking ahead, research and development in the nanomedicine market is expected to offer several novel products that can effectively improve the health of patients suffering from health disorders and illnesses, the report says.

According to the report, the drug delivery market represents the largest application area, while the biomaterials segment represents the fastest-growing application segment for nanomedicine over the years 2006 through 2015. The report notes, however, that the nanomedicine market is highly fragmented and is characterized by the presence of several key and niche players. Major market participants in the nanomedicine market include Abraxis BioScience Inc., AMAG Pharmaceuticals Inc, Arrowhead Research Corp., Crucell N.V., Flamel Technologies S.A., Elan Corporation Plc, Enzon Pharmaceuticals Inc., Life Technologies Corp., Nanosphere Inc., Nektar Therapeutics, Novavax Inc., Oxonica Plc, Par Pharmaceutical Companies Inc., Starpharma Holdings Limited, and Wyeth Pharmaceuticals Inc., among others.

The "Nanomedicine" report covers major market dynamics, trends, issues, and competition pertaining to the market, presenting analytical estimates and projections on market size in terms of dollar sales over the time period 2006-2015. The report enumerates recent developments, mergers, acquisitions, and other strategic industry activities, analyzing the nanomedicine market by the following application areas: Drug Delivery, In Vitro Diagnostics, In Vivo Imaging, Biomaterials, and Other Applications. For more information and purchasing, go to www.strategyr.com/Nanomedicine_Market_Report.asp.

Download Center

  • Safety Metrics Guide

    Is your company leveraging its safety data and analytics to maintain a safe workplace? With so much data available, where do you start? This downloadable guide will give you insight on helpful key performance indicators (KPIs) you should track for your safety program.

  • Job Hazard Analysis Guide

    This guide includes details on how to conduct a thorough Job Hazard Analysis, and it's based directly on an OSHA publication for conducting JHAs. Learn how to identify potential hazards associated with each task of a job and set controls to mitigate hazard risks.

  • A Guide to Practicing “New Safety”

    Learn from safety professionals from around the world as they share their perspectives on various “new views” of safety, including Safety Differently, Safety-II, No Safety, Human and Organizational Performance (HOP), Resilience Engineering, and more in this helpful guide.

  • Lone Worker Safety Guide

    As organizations digitalize and remote operations become more commonplace, the number of lone workers is on the rise. These employees are at increased risk for unaddressed workplace accidents or emergencies. This guide was created to help employers better understand common lone worker risks and solutions for lone worker risk mitigation and incident prevention.

  • EHS Software Buyer's Guide

    Learn the keys to staying organized, staying sharp, and staying one step ahead on all things safety. This buyer’s guide is designed for you to use in your search for the safety management solution that best suits your company’s needs.

  • Vector Solutions

Featured Whitepaper

OH&S Digital Edition

  • OHS Magazine Digital Edition - May 2022

    May 2022

    Featuring:

    • WEARABLE TECHNOLOGY
      How Wearable Technology is Transforming Safety and the Industrial Workplace
    • TRAINING: CONFINED SPACES
      Five Tips to Improve Safety in Confined Spaces
    • INDUSTRIAL HYGIENE
      Monitor for Asbestos to Help Save Lives
    • PPE: FALL PROTECTION
      Fall Protection Can Be Surprising
    View This Issue